Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$423.72
+1.5%
$397.82
$289.36
$425.35
$135.44B1.432.40 million shs2.66 million shs
Pharmerica Co. stock logo
PMC
Pharmerica
$0.00
$22.00
$29.50
N/AN/A283,015 shsN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$285.00
C$298.97
C$280.00
C$327.51
C$703.95M0.81290 shsN/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
+1.50%+6.86%+4.15%+11.69%+23.19%
Pharmerica Co. stock logo
PMC
Pharmerica
0.00%0.00%0.00%0.00%0.00%
Senvest Capital Inc. stock logo
SEC
Senvest Capital
0.00%0.00%+1.78%-8.06%-9.52%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.4879 of 5 stars
2.43.02.53.02.52.52.5
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.75
Moderate Buy$434.932.65% Upside
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/A

Current Analyst Ratings

Latest WGB, PMC, SEC, GS, and NBLS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$460.00 ➝ $470.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$349.00 ➝ $360.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$410.00 ➝ $425.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$435.00 ➝ $440.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$390.00 ➝ $405.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$424.00 ➝ $433.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$446.00 ➝ $479.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$450.00 ➝ $478.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$465.00
4/9/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$440.00 ➝ $460.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$108.42B1.27$41.62 per share10.18$363.61 per share1.17
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$612.76M1.15C$1,478.98 per share0.19C$634.25 per share0.45

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.52B$25.6116.5510.931.348.17%8.65%0.58%7/17/2024 (Estimated)
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
C$151.74M-C$84.10N/AN/A24.76%10.04%6.62%5/14/2024 (Estimated)

Latest WGB, PMC, SEC, GS, and NBLS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/15/2024Q1 2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.54$11.58+$3.04$11.58$12.94 billion$14.21 billion    
3/28/2024Q4 2023
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AC$34.61+C$34.61C$34.61N/AC$166.73 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$11.002.60%+28.06%42.95%3 Years
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/AN/AN/AN/AN/A

Latest WGB, PMC, SEC, GS, and NBLS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Quarterly$2.752.77%5/30/20245/30/20246/27/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
1.98
1.12
0.76
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/A
Senvest Capital Inc. stock logo
SEC
Senvest Capital
56.89
1.35
1.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Pharmerica Co. stock logo
PMC
Pharmerica
89.97%
Senvest Capital Inc. stock logo
SEC
Senvest Capital
N/A

Insider Ownership

CompanyInsider Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.57%
Pharmerica Co. stock logo
PMC
Pharmerica
5.04%
Senvest Capital Inc. stock logo
SEC
Senvest Capital
60.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
45,300324.53 million322.68 millionOptionable
Pharmerica Co. stock logo
PMC
Pharmerica
N/AN/AN/ANot Optionable
Senvest Capital Inc. stock logo
SEC
Senvest Capital
322.47 millionN/ANot Optionable

WGB, PMC, SEC, GS, and NBLS Headlines

SourceHeadline
Fund offering ‘venture capital’ exposure sends investors on meme-like rideFund offering ‘venture capital’ exposure sends investors on meme-like ride
kfgo.com - April 24 at 12:09 AM
Senvest Management Enforcement Action – Electronic CommunicationsSenvest Management Enforcement Action – Electronic Communications
jdsupra.com - April 15 at 11:12 PM
SATRIX Collective Investment Scheme Expands Portfolio with New Securities ListingSATRIX Collective Investment Scheme Expands Portfolio with New Securities Listing
msn.com - April 12 at 10:22 AM
SEC to sue Uniswap DEX amid DeFi regulatory crackdownSEC to sue Uniswap DEX amid DeFi regulatory crackdown
financefeeds.com - April 11 at 1:45 PM
SEC Warns DeFi Firm Uniswap Labs of Potential LawsuitSEC Warns DeFi Firm Uniswap Labs of Potential Lawsuit
wsj.com - April 10 at 6:02 PM
Affinius Capital warns new SEC rules will have significant effect on operationsAffinius Capital warns new SEC rules will have 'significant effect' on operations
bizjournals.com - April 9 at 8:48 PM
FINRA Fines Florida B/D $500K For Not Retaining Business-Related TextsFINRA Fines Florida B/D $500K For Not Retaining Business-Related Texts
wealthmanagement.com - April 8 at 2:13 PM
SEC Charges Advisory Firm Senvest Management with Recordkeeping and Other FailuresSEC Charges Advisory Firm Senvest Management with Recordkeeping and Other Failures
tradersmagazine.com - April 5 at 4:56 AM
Global View Capital Advisors Selects OneVest as its Wealth Management Platform PartnerGlobal View Capital Advisors Selects OneVest as its Wealth Management Platform Partner
tmcnet.com - April 4 at 6:56 PM
Senvest latest rapped by SEC over off-channel commsSenvest latest rapped by SEC over off-channel comms
complianceweek.com - April 4 at 3:53 AM
RIA Senvest To Pay $6.5M for Text Message Record-Keeping FailuresRIA Senvest To Pay $6.5M for Text Message Record-Keeping Failures
wealthmanagement.com - April 3 at 5:52 PM
Senvest Capital Reports Results for the Year Ended December 31, 2023Senvest Capital Reports Results for the Year Ended December 31, 2023
finance.yahoo.com - March 28 at 7:38 PM
Why did this prime Palm Beach condo sell for $11.93M, about $3M less than 2022 sale?Why did this prime Palm Beach condo sell for $11.93M, about $3M less than 2022 sale?
palmbeachdailynews.com - March 27 at 3:41 PM
Vibrant Capital Market Vital For Economy - SECVibrant Capital Market Vital For Economy - SEC
msn.com - March 23 at 10:13 AM
SPDR S&P Capital Markets ETF declares quarterly distribution of $0.5558SPDR S&P Capital Markets ETF declares quarterly distribution of $0.5558
msn.com - March 18 at 1:14 PM
SEC climate disclosure rule faces legal gantletSEC climate disclosure rule faces legal gantlet
eenews.net - March 11 at 7:17 PM
Starwood Capital Entities and Jaws Mustang Acquisition sign non-binding LOIStarwood Capital Entities and Jaws Mustang Acquisition sign non-binding LOI
msn.com - March 11 at 2:16 PM
Satrix Collective Investment Scheme Adds New Securities to JSE ListingSatrix Collective Investment Scheme Adds New Securities to JSE Listing
msn.com - March 11 at 9:16 AM
Transcend Capital Advisors Adds Elite Amateur Blades Brown To NIL RosterTranscend Capital Advisors Adds Elite Amateur Blades Brown To NIL Roster
businesswire.com - March 7 at 8:48 PM
Capital One Stock in Focus After $35B Deal To Buy Discover Financial—Key Levels to WatchCapital One Stock in Focus After $35B Deal To Buy Discover Financial—Key Levels to Watch
msn.com - February 19 at 11:39 PM
SuRo Capital Buy Rating: Strategic Actions and Undervalued NAV Present Investment OpportunitySuRo Capital Buy Rating: Strategic Actions and Undervalued NAV Present Investment Opportunity
markets.businessinsider.com - February 15 at 9:24 PM
Soros Fund, AQR, Millennium bought NYCB shares in Q4Soros Fund, AQR, Millennium bought NYCB shares in Q4
msn.com - February 15 at 12:25 AM
Magna International and Institutional Investors Adjust Ownership Stakes in FiskerMagna International and Institutional Investors Adjust Ownership Stakes in Fisker
msn.com - February 14 at 7:25 PM
Capital Securities Corp. Ltd.Capital Securities Corp. Ltd.
wsj.com - February 9 at 8:16 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

The Goldman Sachs Group logo

The Goldman Sachs Group

NYSE:GS
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.
Pharmerica logo

Pharmerica

NYSE:PMC
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.
Senvest Capital logo

Senvest Capital

TSE:SEC
Senvest Capital Inc., through its subsidiaries, holds investments in equity and real estate holdings in the United States and internationally. The company invests in derivative financial instruments comprising primarily options and warrants to purchase or sell equities, equity indices and currencies, equity swaps, foreign currency forward contracts, and foreign currency futures contracts. It also has investments as minority interests in private entities whose main assets are real estate properties; and real estate income trusts and partnerships. In addition, the company invests in self-storage facilities in Spain. The company was formerly known as Sensormatic Canada Limited and changed its name to Senvest Capital Inc. in April 1991. Senvest Capital Inc. was incorporated in 1968 and is headquartered in Montreal, Canada.